Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region

• Päätekijät: Agnese Gagliardi (Tekijä), Francesco Salvatore Iaquinta (Tekijä), Rosa Daniela Grembiale (Tekijä), Caterina De Sarro (Tekijä), Antonio Fabiano (Tekijä), Domenico Fraija (Tekijä), Caterina Palleria (Tekijä), Rossella Romeo (Tekijä), Adele Emanuela De Francesco (Tekijä), Maria Diana Naturale (Tekijä), Rita Citraro (Tekijä), Luca Gallelli (Tekijä), Antonio Leo (Tekijä), Giovambattista De Sarro (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2022-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

<b>Background:</b> The introduction of biological agents into the clinical armamentarium has modified the management of moderate-severe inflammatory arthritis (IA). However, these drugs can lead to serious adverse events (SAEs) and unpredictable adverse events (AEs) that are difficult to...